[HTML][HTML] Nutrient-stimulated insulin secretion in mouse islets is critically dependent on intracellular pH

SC Gunawardana, JV Rocheleau, WS Head… - BMC Endocrine …, 2004 - Springer
SC Gunawardana, JV Rocheleau, WS Head, DW Piston
BMC Endocrine Disorders, 2004Springer
Background Many mechanistic steps underlying nutrient-stimulated insulin secretion (NSIS)
are poorly understood. The influence of intracellular pH (pH i) on insulin secretion is widely
documented, and can be used as an investigative tool. This study demonstrates previously
unknown effects of pH i-alteration on insulin secretion in mouse islets, which may be utilized
to correct defects in insulin secretion. Methods Different components of insulin secretion in
mouse islets were monitored in the presence and absence of forced changes in pH i. The …
Background
Many mechanistic steps underlying nutrient-stimulated insulin secretion (NSIS) are poorly understood. The influence of intracellular pH (pHi) on insulin secretion is widely documented, and can be used as an investigative tool. This study demonstrates previously unknown effects of pHi-alteration on insulin secretion in mouse islets, which may be utilized to correct defects in insulin secretion.
Methods
Different components of insulin secretion in mouse islets were monitored in the presence and absence of forced changes in pHi. The parameters measured included time-dependent potentiation of insulin secretion by glucose, and direct insulin secretion by different mitochondrial and non-mitochondrial secretagogues. Islet pHi was altered using amiloride, removal of medium Cl-, and changing medium pH. Resulting changes in islet pHi were monitored by confocal microscopy using a pH-sensitive fluorescent indicator. To investigate the underlying mechanisms of the effects of pHi-alteration, cellular NAD(P)H levels were measured using two-photon excitation microscopy (TPEM). Data were analyzed using Student's t test.
Results
Time-dependent potentiation, a function normally absent in mouse islets, can be unmasked by a forced decrease in pHi. The optimal range of pHi for NSIS is 6.4–6.8. Bringing islet pHi to this range enhances insulin secretion by all mitochondrial fuels tested, reverses the inhibition of glucose-stimulated insulin secretion (GSIS) by mitochondrial inhibitors, and is associated with increased levels of cellular NAD(P)H.
Conclusions
Pharmacological alteration of pHi is a potential means to correct the secretory defect in non-insulin dependent diabetes mellitus (NIDDM), since forcing islet pHi to the optimal range enhances NSIS and induces secretory functions that are normally absent.
Springer